DKDong Rak Kwon

Dong Rak Kwon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dong Rak Kwon has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Evaluation of microcurrent as an adjunct to donepezil therapy in an Alzheimer's disease mouse model: a pilot study

    by Eun Ho Kim, Yoon-Jin Lee, Yong Suk Moon, Oh Dae Kwon, Dong Rak Kwon

    Alzheimer's disease (AD) is one of the most common neurodegenerative disorders that affects the elderly aged above 65 years (Esiri and Chance, 2012). With over 35.6 million affected and a rate of 7.7 million new cases globally, AD remains one of the major causes of poor quality of life for the elderly (Pardo-Moreno et al., 2022). A loss of episodic memory attributable to the cognitive impairments in the regions responsible for executive function, visuospatial ability, among others, characterises AD. Synaptic loss and cholinergic neuronal loss observed in AD are attributable to senile plaque depositions of parenchymal amyloid-β (Aβ) (Pardo-Moreno et al., 2022). Histologically, neuronal loss is often associated with neuroinflammation and neurodegeneration. Cholinesterase inhibitors such as donepezil are routinely used to treat AD (Kuwahata et al., 2021). However, several studies such as by Yang et al described that large doses of donepezil are essential to cause a significant change in the cognitive function (Yang et al., 2013).In recent years, several tissue engineering and regenerative medicine advancements have been studied. Microcurrent therapy has emerged as one of the non-invasive and impactful treatment protocols for AD-affected patients (Kong et al., 2024). The study by Li et al. highlighted the potential for axonal regeneration through Wallerian degeneration (Li et al. 2023). Nerve stimulation, when applied at a low intensity spectrum, has been accepted as a sustainable treatment option as a result of its low discomfort to the patients (Hassan et al., 2020). A critical aspect of AD is the degeneration of tubulin proteins attributable to abnormalities in the tau protein, resulting in microtubular disintegration and disruption of axonal transport. Additionally, neuronal death is primarily caused by oxidative stress and mitochondrial dysfunction (Kim et al., 2024a).Emerging evidence has shown that intracellular signaling pathways play a pivotal role in both neurodegeneration and therapeutic response in AD (Zhang et al., 2023). The PI3K-AKT axis is essential for neuronal survival and synaptic plasticity, mediating anti-apoptotic responses and regulating metabolism (Sun et al., 2019). AMPK, an energy-sensing kinase, promotes mitochondrial function and autophagic clearance, providing protection under cellular stress (Huang et al., 2022). Importantly, inactivation of GSK-3β through phosphorylation at Ser9 has been shown to reduce tau hyperphosphorylation and mitigate microtubule destabilizationtwo hallmarks of AD pathology (Medina and Avila, 2014). Additionally, the JAK2/3-STAT signaling pathway, beyond its classical role in cytokine-mediated immune responses, has been implicated in neuroimmune modulation and glial-driven repair in the CNS (Song and Suk, 2017).Activation of JAK2/3, when uncoupled from pro-inflammatory cytokine induction, may contribute to homeostatic or protective responses in neurodegenerative settings (Ha et al., 2022, Gabbouj et al., 2019) .Therefore, we propose that while donepezil mitigates neuronal loss, microcurrent (MC) therapy may enhance regenerative signaling and restore intracellular homeostasis. The current study aims to evaluate the therapeutic efficacy of combined treatment with donepezil and MC therapy, focusing on their potential to activate PI3K-AKT-AMPK survival signaling, inhibit GSK-3β activity, and modulate JAK2/3-related immune signaling, ultimately inducing synergistic neuroprotection in AD.The chemicals used in this study include the following. APP (Sigma Aldrich, St. Louis, MO, USA), Iba-1 (ab178846, 1:1000, abcam, Cambridge, CAM, UK), TGF, TNF-α (sc-52746, 1:1000, Santa Cruz), IL-1β (sc-7884, 1:1000, Santa Cruz), cresyl violet (C5042, Amyloid-β (sc-53822, 1:500, Santa Cruz, Dallas, TX, USA), β-actin (sc-8432, 1:1000, Santa Cruz), Alexa594 anti-mouse (A11005, 1:1000, Invitrogen), Anti-goat rabbit (ADI-SAB-300-J, 1:4000, Enzo Life Sciences, Farmingdale, NY, USA), Anti-goat mouse (ADI-SAB-100-J, 1:4000, Enzo Life Sciences), ABC kit (PK-6100, DAB kit (SK-4100, Vector), and Alexa488 anti rabbit (A32790, 1:1000, Invitrogen, Waltham, MA, USA), Vector, Newark, CA, USA).Microcurrent was applied at the set times and the set dosage (Ecure, Buan, Republic of Korea).Electricity passed through the cage floor and reached the mice's brain tissues. Mice are nocturnal animals, and thus the microcurrent is applied during their active time of the day. Kim et al. provided insight into the effectiveness of stepform waveform in cognitive repair in AD mice, and thus the same was applied (Kim et al., 2024b). Wave superposition and a stepform waveform of 0, 1.7, 3.4, and 5 V. The base frequency of 7 Hz with an extra 44 kHz frequency superimposition was set, along with the 5 V voltage and the microcurrent with a magnitude of 1 μA (500 ohms). This dosage was administered for 4 weeks in six-hour sessions.Mice (transgenic) with B6SJL Tg (APPSwFlLon, PSEN1*M146L* L286V) 6799Vas/Mmjax strain from Jackson Laboratory, located in Bar Harbor, ME, USA. WT and Tg-5xFAD AD mice were divided into different groups and were exposed to microcurrents from the age of 1.5 months. Genetic advancement of Aβ aggregation in Tg-5xFaD AD mice is initiated through this treatment. Permissions were obtained from The Institutional Animal Care and Use Committee granted permission to conduct these experiments (IRB no.: DCIAFCR-240613-13-Y), and the global standards of treating animals were adhered to. Post the 7-day adaptation period, a small group of Tg-5xFAD mice were randomly assigned to the AD model group or the microcurrent plus AD model group (n = 7 per group). Followed by further categorization into the + NC group (n = 7 per group) or Donepezil, or Donepezil plus MC or the normal control (NC) group. The microcurrent therapy was initiated and is followed by behavioral analysis.The Novel Object Recognition test includes two objects, one that...

  • A comprehensive review of ultrasonographic imaging in athletic elbow injuries: a compartment-based approach

    by Dong Rak Kwon, EunKuk Kim

    Elbow injury rates are markedly higher among collegiate athletes than in the general population; however, this elevated incidence is largely driven by overhead throwing sports and does not represent a uniform risk across all athletes. Elbow disorders represent a significant diagnostic challenge in sports medicine due to the intricate anatomy of the joint. High-resolution ultrasonography has become an indispensable first-line imaging modality, offering superior spatial resolution for superficial structures and the unique capability for real-time dynamic assessment. This review illustrates the ultrasonographic spectrum of common elbow injuries in athletes, including epicondylopathy, ulnar collateral ligament insufficiency, and nerve entrapment syndromes. By employing a systematic, compartment-based approach categorizing findings into anterior, medial, lateral, and posterior zones, radiologists can ensure a comprehensive evaluation. Particular emphasis is placed on dynamic maneuvers such as valgus stress for ulnar collateral ligament stability and flexion–extension for ulnar nerve subluxation, which provide functional insights that are often unavailable on static magnetic resonance imaging. Furthermore, emerging adjunctive techniques, such as sonoelastography, may provide complementary information on tissue stiffness and integrity, potentially improving lesion characterization in specific athletic elbow conditions. Understanding these imaging patterns is crucial for accurate diagnosis and optimized management in athletes.

  • Open Access

    Investigating the Neuroprotective Effects of Peripheral Nerve Microcurrent Stimulation in a Mouse Model of Parkinson’s Disease

    by Eun Ho Kim, Yoon-Jin Lee, Yong Suk Moon, Dong Rak Kwon

    Kim EH, et al. Brain Neurorehabil. 2026 ;19:e3. https://doi.org/10.12786/bn.2026.19.e3

  • Open Access

    Evaluation of microcurrent as an adjunct to donepezil therapy in an Alzheimer’s disease mouse model: a pilot study

    by Eun Ho Kim, Yoon-Jin Lee, Yong Suk Moon, Oh Dae Kwon, Dong Rak Kwon

    Background: Alzheimer’s disease (AD) is a neurodegenerative disorder due to Aβ plaque accumulation, followed by loss of synapses and decline in cognitive abilities. Donepezil is currently one of the standard pharmacological treatments for Alzheimer’s disease. Recently, microcurrent (MC) therapy has emerged as a non-pharmacological adjunct for AD management. Recently, microcurrent therapy emerged as a non-pharmacological alternative to treat AD. Objective: The study investigates the therapeutic outcomes of the MC as an adjuvant to donepezil in mitigating cognitive dysfunction in the transgenic mouse model (5XFAD). Methods: Transgenic 5xFAD mice were assigned to the control, donepezil, MC, or MC + donepezil (combination) groups. Behavioral performance was assessed using the novel object recognition (NOR) and radial arm maze (RAM) tests. Amyloid burden, glial activation, cytokine expression, apoptotic signaling, and intracellular pathways (PI3K–AKT, AMPK, and JAK2/3) were analyzed by immunohistochemistry and Western blotting. Results: Combined treatment with donepezil and microcurrent showed a statistically significant improvement in cognitive performance compared to monotherapies. Aβ plaque burden in the cortex and hippocampus was reduced by ~68%, exceeding reductions observed with either treatment alone. Western blot analyses showed reduced levels of glial markers (Iba-1, GFAP, CD68) and cytokines (TNF-β, IL-1β) in both donepezil and combination groups compared with untreated 5xFAD mice, with no significant difference between 5xD and 5xD + MC. Apoptotic markers (cleaved caspase-3, cleaved PARP) were significantly reduced in both treatment groups compared with untreated controls, but not significantly different between donepezil and combination therapy. Both treatments modulated AKT, AMPKα, PI3K, GSK-3β, and JAK2/3 signaling, while combination therapy showed pathway-specific additional effects on PI3K and JAK3 phosphorylation and on the inhibitory phosphorylation of GSK-3β compared with donepezil alone. Conclusion: Donepezil combined with microcurrent therapy improved cognitive performance and produced additional effects on selected signaling pathways compared with donepezil alone. While both treatments reduced Aβ burden and attenuated glial activation, the addition of microcurrent produced additional effects on GSK-3β, PI3K, and JAK3 signaling. These findings support further investigation of microcurrent as an adjunct to donepezil therapy in AD.


  • Open Access

    In Vitro and In Vivo Comparative Analysis of Muscle Regenerative Processes Induced by Different Microcurrent Waveforms in Skeletal Muscle Atrophy

    by Yoon-Jin Lee, Eun Sang Kwon, Yong Suk Moon, Dong Rak Kwon

    This study aimed to evaluate the regenerative effects of various microcurrent waveforms in cast-induced gastrocnemius muscle atrophy in rabbits, integrating both in vitro and in vivo analyses. After two weeks of enforced hindlimb immobilization via casting, twenty-four rabbits were divided into four groups and treated for two weeks: Group-1 (control) received sham microcurrent, Group-2 was treated with a square waveform microcurrent, Group-3 with a sine waveform, and Group-4 with a triangular waveform. Treatments were administered daily for one hour. Calf circumference, muscle thickness (via ultrasound), tibial nerve CMAP, muscle fiber CSA, and protein expression (via Western blot analysis) were assessed. Among the groups, the sine waveform microcurrent resulted in significantly enhanced recovery across all measured parameters (p < 0.05), showing superior improvements in muscle thickness, CMAP amplitude, and fiber CSA. Immunohistochemical analysis revealed increased expression of proliferation and angiogenesis markers, including BrdU, PCNA, VEGF, and PECAM-1, while Western blotting demonstrated robust upregulation of myogenic regulatory factors such as MyoD and myogenin. Furthermore, levels of inflammatory and apoptotic markers, including TNF-α, NF-κB, and cleaved caspase-3, and stress response proteins, including p-CHK1 and p-CHK2, were markedly reduced. Collectively, these findings indicate that sine waveform microcurrent stimulation most effectively promotes muscle regeneration in both dexamethasone-induced C2C12 myoblasts and cast-induced muscle atrophy, underscoring its therapeutic potential and warranting further studies to optimize clinical application parameters.


  • Open Access

    In Vitro and In Vivo Comparative Analysis of Muscle Regenerative Processes Induced by Different Microcurrent Waveforms in Skeletal Muscle Atrophy

    by Yoon-Jin Lee, Eun Sang Kwon, Yong Suk Moon, Dong Rak Kwon

    Objective: To evaluate the regenerative effects of various microcurrent waveforms in cast-induced gastrocnemius muscle atrophy in rabbits, with comprehensive in vitro and in vivo analyses. Methods: After two weeks of enforced hindlimb immobilization via casting, twenty-four rabbits, four studied groups were formed. Each group received a different treatment for two weeks: Group 1 (control) was given sham microcurrent; Group 2 was treated with a square waveform microcurrent; Group 3 with a sine waveform; and Group 4 with a tri-angular waveform. Treatments were administered daily for one hour. We assessed calf circumference, muscle thickness via ultrasound, tibial nerve CMAP, muscle fiber CSA, and protein expressions through Western blot analysis. Results: Notably, the sine waveform group (Group 3) showed significantly enhanced recovery across all measured parameters (p < 0.05). This group exhibited superior im-provements in muscle thickness, CMAP amplitude, and fiber CSA. Detailed immuno-histochemical analysis showed a marked rise in the expression of cellular proliferation and angiogenesis markers such as BrdU, PCNA, VEGF, and PECAM-1. Furthermore, western blot analysis highlighted a robust upregulation in myogenic regulatory factors including MyoD and Myogenin. It also showed a reduction in inflammatory and apop-totic markers such as TNF-α, NF-κB, cleaved caspase-3, and a notable decrease in stress response proteins p-CHK1 and p-CHK2. Conclusion: Sine waveform microcurrent stimulation was the most potent in promoting muscle regeneration in both dexamethasone-induced C2C12 myoblasts and cast-induced muscle atrophy, highlighting its significant therapeutic potential. Further studies are warranted to refine clinical application parameters.


  • Top Cited Papers
    Open Access

    3D bioprinted multi-layered cell constructs with gradient core-shell interface for tendon-to-bone tissue regeneration

    by WonJin Kim, Dong Rak Kwon, Hyeongjin Lee, JaeYoon Lee, Yong Suk Moon, Sang Chul Lee, Geun Hyung Kim

    Rotator cuff tears are common among physically active individuals and often require surgical intervention owing to their limited self-healing capacity. This study proposes a new bioprinting approach using bone- and tendon tissue-specific bioinks derived from decellularized extracellular matrix, supplemented with hydroxyapatite and TGF-β/poly(vinyl alcohol) to fabricate engineered tendon-to-bone complex tissue. To achieve this goal, a core-shell nozzle system attached to a bioprinter enables the effective and simultaneous fabrication of aligned tendon tissue, a gradient tendon-bone interface (TBI), and a mechanically improved bone region, mimicking the native tendon-to-bone structure. In vitro evaluation demonstrated the well-directed differentiation of human adipose stem cells towards osteogenic and tenogenic lineages in the bone and tendon constructs. In the graded TBI structure, further facilitated fibrocartilage formation and enhanced the integration of tendon-to-bone tissues compared to non-graded structures in vitro. Furthermore, using a rabbit rotator cuff tear model, implantation of the biologically graded constructs significantly promoted the rapid regeneration of full-thickness tendon-to-bone tissue, including the formation of a high-quality TBI in vivo. This bioprinting approach not only improved mechanical properties and tissue integration but also enhanced angiogenesis and extracellular matrix (ECM) formation, demonstrating its potential as a promising platform for the regeneration of tendon-to-bone complex tissues.


  • Open Access

    Electroceuticals in Muscle Regeneration: Mechanisms and Therapeutic Potential

    by Dong Rak Kwon

    Dong Rak Kwon, M.D., Ph.D.. Clinical Pain 2024;23:66-72. https://doi.org/10.35827/cp.2024.23.2.66

  • Open Access

    The effectiveness of care robots in alleviating physical burden and pain for caregivers: Non-randomized prospective interventional study – Preliminary study

    by Jae Ik Jung, Yoo Seok Jeong, Dong Rak Kwon

    Background: Caregiver burden significantly affects both patients and caregivers but is often overlooked in clinical practice. Physical and emotional strain on caregivers can compromise the quality of care. Care robots are emerging as solutions to alleviate these burdens by assisting with routine tasks, thereby reducing caregivers’ physical strain and stress. Therefore, a prospective, non-randomized, interventional clinical trial was designed to identify changes in caregivers’ physical activities due to care robot use and explore the associated benefits. Methods: Twenty-two caregivers (1 male and 21 female; mean age, 62.05 years) were participated. We analyzed the impact of care robots on reducing physical burden and assessed caregivers’ satisfaction with these robots by examining care activity history, pain levels, muscle activities, and data for each physical care activity (e.g., transfer, reposition, feeding, and toileting), categorizing them based on whether a care robot was used. Care robots that assist in transfer, repositioning, feeding, and toileting activities were used in a clinical trial. Muscle activity was measured during maximum voluntary isometric contraction using electromyography sensors placed on the upper trapezius, biceps brachii, and erector spinae muscles. Results: During care robot use, we observed a statistically significant decrease in the distance and number of steps required for assisting with repositioning. However, the caregiving activity time increased when the robots assisted with transfer, feeding, and toileting (P < .001). Pain was significantly reduced during transfer and toileting activities using the care robot (P < .001) as well as during feeding activity (P = .040). Maximum voluntary isometric contraction showed a significant reduction in the upper trapezius, biceps brachii, and erector spinae muscles during the 4 care activities when using the robot, and these findings were consistent across the 3 sessions (P < .001). In the survey, caregivers indicated that “transfer-assisting” care robots were the most needed (15 respondents, 68.2%). Conclusion: In this study, we demonstrated that employing care robots can aid in mitigating muscle overuse among caregivers, potentially alleviating pain due to musculoskeletal conditions.


  • Open Access

    The Neuroprotective Effects of Peripheral Nerve Microcurrent Stimulation Therapy in a Rat Model of Middle Cerebral Artery Occlusion

    by Yoon-Jin Lee, Eun Sang Kwon, Yong Suk Moon, Jeong-Rang Jo, Dong Rak Kwon

    This study investigated the neuroprotective effects of peripheral nerve microcurrent stimulation therapy in a rat model of middle cerebral artery occlusion (MCAO). Twenty 8-week-old male Sprague Dawley rats weighing 300–330 g were categorised into group A, serving as the healthy control; group B, including rats subjected to MCAO; group C, including rats receiving microcurrent therapy immediately after MCAO, which was continued for one week; and group D, including rats receiving microcurrent therapy one week before and one week after MCAO. A gross morphological analysis, behavioural motion analysis, histological examination, immunohistochemistry, and Western blotting were conducted. Microcurrent therapy significantly reduced ischaemic damage and pyramidal cells of the hippocampus CA1 region. Haematoxylin and eosin staining revealed infarction areas/viable pyramidal cell numbers of 0%/94.33, 28.53%/40.05, 17.32%/80.13, and 5.38%/91.34 in groups A, B, C, and D, respectively (p < 0.001). A behavioural analysis revealed that the total distances moved were 1945.24 cm, 767.85 cm, 1781.77 cm, and 2122.22 cm in groups A, B, C, and D, respectively (p < 0.05), and the mean speeds were 6.48 cm/s, 2.50 cm/s, 5.43 cm/s, and 6.82 cm/s, respectively (p < 0.05). Inflammatory markers (cluster of differentiation 68, interleukin-6, and tumour necrosis factor-α) significantly decreased in the treated groups (p < 0.001). Western blotting revealed reduced proinflammatory, oxidative stress, and apoptosis-related protein levels, along with increased angiogenic factors and mitogen-activated protein kinase (MAPK) pathway modulation in the treated groups. Peripheral nerve microcurrent stimulation therapy effectively mitigates ischaemic damage, promotes recovery, reduces inflammation, and modulates protein expression, emphasising its potential as a therapeutic strategy for ischaemic stroke.